Why i bought back into to the Suda Story last Wednesday, page-4

Hi pogues 

I have been trying to start a new thread  titled "sud-001 growth to 2025" but for whatever reason no matter how hard I thumped the keys I couldn't get it to fire up. So that is my way of apologising me piggy backing your post on this thread because its the most relevant to the (possibility of a) SUD-001 event tomorrow. For those old enough to remember....try to recall the Orson Welles Radio adaption of War of the Worlds.

Hi All

Thought that I would do some follow up on SUD-001 as it is all the talk at the moment and hopefully that will remain to be the case for a little while at least. 

Checking through a lot of old stuff about SUD-001, the easiest and best read is post # 19465112 dated 28/9/16 by our good friend livas1 who still makes great contributions to the SUD forum despite no longer holding. He also includes in his post a link to http;//www.prnewswire.com/news-rele...ive-market-growth-through-2025-30033316.html (use the link from livas1)

The headline from the linked article reads:-

First-in Class Anti-CRGP Monoclonal Antibodies for Migraine Prevention for Eli Lilly, Teva, Amgen/Novartis and Alder will Drive Market Growth Through 2025.

The following snippets are highlights:-

1)...the migraine market will grow from $3B in 2015 to over $10B in 2025

2)...SUDAs sumatriptan oral spray SUD-001 is expected to launch during the forecast period (2015 - 2025)

The timing seems about right, fingers crossed.

kippax

PS only one more sleep.